Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis [PDF]
Frontiers in Pharmacology, 2023 Introduction: Impressive advances in immunotherapy especially immune checkpoint inhibitors have made great progress in treating multiple cancers but can also cause serious even incurable immune-related adverse events, mostly found in colitis, dermatitis,
Qian Guo +6 more
doaj +3 more sources
Aplastic anaemia associated with bendamustine therapy – a rare side effect [PDF]
European Journal of Case Reports in Internal MedicineIntroduction: During treatment for malignant lymphoma, cytopenia can develop for several reasons. This can range from mild cytopenias leading to infection and bleeding to full-blown drug-induced aplastic anaemia.
Salman Khan +6 more
doaj +4 more sources
What causes aplastic anaemia? [PDF]
Leukemia, 2023 Aplastic ...
Gale RP +8 more
europepmc +2 more sources
Multidisciplinary approaches to study anaemia with special mention on aplastic anaemia (Review). [PDF]
Int J Mol MedAnaemia is a common health problem worldwide that disproportionately affects vulnerable groups, such as children and expectant mothers. It has a variety of underlying causes, some of which are genetic.
Sankar D, Oviya IR.
europepmc +2 more sources
A case of strongyloidiasis with aplastic anaemia: A common disease with an uncommon presentation [PDF]
IDCases, 2023 Strongyloidiasis is an opportunistic infection caused by the nematode helminth Strongyloides stercoralis and transmitted mostly via soil. The disease is usually asymptomatic, limited, and long-standing.
Alka Singh, Pallavi Prasad, Anurag Singh
doaj +2 more sources
A rare case report of severe aplastic anaemia caused by long-term use of zidovudine [PDF]
BMC Infectious DiseasesBackground Zidovudine is an antiviral drug used to treat acquired immune deficiency syndrome (AIDS). Anaemia is a common adverse effect of zidovudine that usually occurs in the first 2 to 4 weeks of initial treatment. Here, we describe a patient with HIV
Jing Zhou +6 more
doaj +2 more sources
Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting
Hematology, 2018 Objective: The thrombopoietin mimetic eltrombopag has been used in clinical trials for the frontline and salvage treatment of aplastic anaemia (AA). Eltrombopag was investigated in AA patients on a non-trial all-comer basis.
Carol Y M Cheung, Harinder Gill
exaly +2 more sources
A Unique Constitutional Robertsonian Translocation t(13;14) Associated with Severe Aplastic Anaemia [PDF]
Journal of Clinical and Diagnostic Research, 2021 Aplastic anaemia is characterised by cytopenias and hypocellular bone marrow without any evidence of marrow fibrosis or marrow infiltration. There is no specific cytogenetic abnormality associated with aplastic anaemia.
Bhupendra Singh +4 more
doaj +1 more source
A child with Dengue-Associated Aplastic Anaemia in Bangladesh: A Case Report with Literature Review
Haematology Journal of Bangladesh, 2023 Dengue virus is endemic in Bangladesh. It is known to cause thrombocytopenia through direct infection of bone marrow megakaryocytes, but very rarely it may also cause tri-linear marrow suppression leading to secondary aplastic anaemia.
Eshita Reza Khan, Md. Salim
doaj +1 more source
Current Medicine Research and Practice, 2022 Aplastic anaemia can develop due to various viral infections. However, SARS-CoV-2 infection evolving into aplastic anaemia is rarely seen. Here, we present a case of a 6-year-old boy who presented with epistaxis and rashes all over the body after ...
Akanksha Bhatia +2 more
doaj +1 more source